Latest Updates of Companies in the Antiviral and Antimicrobial Technology Market
| Company | Headquarters | Latest Update |
| Gilead Sciences | United States | A leader in antiviral management, specifically known for Remdesivir. |
| Pfizer | United States | Pfizer produces a broad range of antibiotics like Zithromax and Zosyn for hospital and outpatient use. |
| Merck & Co. | United States | Recent advancement of life sciences with EnvisionTEC 3D Bioplotter. Achieve precision bioprinting for tissue engineering and medical care labs. |
| GSK | United Kingdom | This organization is known as Augmentin and is heavily involved in infectious disease management. |
| Shionogi | Japan | Specializes in new treatments, involving Gram-negative therapies such as Cefiderocol. |
Recent Developments in Antiviral and Antimicrobial Technology Market
- In November 2025, Biobond launched its sustainable three-layer antimicrobial coating in Mexico, partnering with Insumos Maez. Designed for commercial, residential, and industrial facilities, the launch aligns with President Claudia Sheinbaum’s nationwide infrastructure boom, protecting new buildings, hospitals, and transit hubs ahead of upcoming global events.
- In July 2025, Researchers at the National Graphene Institute, in partnership with Smith & Nephew, developed a light-activated graphene oxide coating that offers sustained antimicrobial protection via silver ions. Published in Small, this technology aims to enhance hygiene across healthcare and industrial applications.
Market Growth
The global antiviral and antimicrobial technology market size was estimated at USD 16.84 billion in 2025 and is predicted to increase from USD 18.85 billion in 2026 to approximately USD 51.93 billion by 2035, expanding at a CAGR of 11.92% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking